
Angela Duffy has been appointed as Managing Director for our European based ad hoc research teams. Angela has been an integral part of Research Partnership for 19 years, witnessing its evolution into a global organization and forming part of Inizio Advisory. Her outstanding contributions to the company’s growth and expansion has led to her well-earned appointment to this new position. Angela will now spearhead the strategic growth of our European teams, ensuring our clients receive high quality insights and solutions to their business challenges.
In addition, Grzegorz Stanczyk has joined Research Partnership as Operations Director, having previously worked at Hall and Partners. With a wealth of experience in operational strategy within the market research industry, Grzegorz will play a pivotal role in supporting our ad-hoc research teams and overseeing our Compliance and Commercial Affairs functions. His expertise in client and supplier contracting, as well as MSA negotiations, will help to enhance our operations.
Helen Cox has joined the business as Senior Commercial Director. Helen is an accomplished insights professional with over 25 years’ experience, having led client engagement across healthcare clients in her most recent role at Ipsos, both in defining the overall strategy and leading client accounts. Helen brings a wealth of experience in strengthening client partnerships, understanding clients’ businesses, and bringing the very best expertise to every engagement, which will help to strengthen our commercial strategy at Research Partnership.
CEO of Research Partnership, Gareth Phillips, commented “I am delighted to congratulate Angela on her new appointment and welcome Grzegorz and Helen to the team. Angela’s expertise will be instrumental in delivering enhanced value to our clients within the European sector. Grzegorz and Helen both bring a wealth of knowledge and fresh perspectives to our dynamic workforce, and I look forward to collaborating with them both as we strengthen our Operational and Commercial capabilities across our global teams.”
Find out more and explore a range of resources at Research Partnership.
This content was provided by Inizio
Latest Content from Inizio
We are delighted to be presenting a paper at the Pharma China Annual Forum on 14th April 2017 in Shanghai, China.
A few key considerations for conducting healthcare market research in the Gulf
Our client wanted to find out how best to develop an implantable delivery device technology with add-on services in the Multiple Sclerosis market. We were tasked with finding out whether such a…
Live webinar: Thursday 30th March 10:00 EDT / 15:00 BST / 16:00 CEST
Published in eyeforpharma February 2017 by Marc Yates
Industry Magazine Pharma Times has partnered with Catalyst Corporate Finance to publish a detailed analysis of the 50 fastest growing private, independently owned pharma companies in the UK and Research…
Why can understanding and improving women’s health in emerging markets be challenging? What strategies can global pharma develop to support women and overcome these challenges? Associate Director Rachel Howard and…
SLE is a progressive and debilitating disease which affects 5 million people worldwide.
Pegasus, an Ashfield company, part of UDG Healthcare plc, is proud to announce the launch of its new propriety model for planning in health – CHANGE – which was developed…
Understanding the role pharmaceutical companies can play in fighting today’s global health pandemics
